I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Extraction of teeth is one of the most common procedures carried out in the field of oral surgery. Reasons for routine tooth extractions have been widely reported in medical literature.\[[@ref1]\] Extraction should be pain-free. Intraoperative pain management is of great importance in extraction procedure.

Local anesthesia forms the backbone of pain control techniques in dentistry, and there has been substantial research interest in finding safer and more effective local anesthetics.\[[@ref2]\] The history of local anesthesia started in 1859 when cocaine was isolated by Niemann. In 1884, the ophthalmologist Koller was the first, who used cocaine for topical anesthesia in ophthalmological surgery. Lofgren synthesized lidocaine, which was the first "modern" local anesthetic agent since it is an amide-derivate of diethyl amino acetic acid. Lidocaine was marketed in 1948 and is up till now the most commonly used local anesthetic in dentistry worldwide.\[[@ref3]\] Articaine hydrochloride was synthesized by Rushing and colleagues in 1969 and first marketed in Germany in 1976. Its use gradually spread, entering North America in Canada in 1983, and the United Kingdom in 1998.\[[@ref4]\]

Articaine hydrochloride is an amide local anesthetic, 4-methyl-3 (2 \[propylamino\] propionamido)-2-thiophenecarboxylic acid, methyl ester hydrochloride. It is unique among amide local anesthetics in that it contains a thiophene group, which increases its liposolubility, and is the only widely used amide local anesthetic that also contains an ester group. The ester group enables articaine to undergo biotransformation in the plasma (hydrolysis by plasma esterase) and in the liver (by hepatic microsomal enzymes).\[[@ref4]\] The primary metabolite, articainic acid, is inactive.\[[@ref5]\] Articaine and its metabolites are eliminated through the kidneys. Approximately 5%--10% of articaine is excreted unchanged.\[[@ref6]\] No differences in toxicity were noted between 4% articaine and lower concentrations.\[[@ref7][@ref8][@ref9][@ref10][@ref11]\]

Pain on palatal injection is a very commonly experienced symptom in dentistry. A number of techniques may be used to reduce the discomfort of intraoral injections,\[[@ref12][@ref13]\] the application of topical anesthetic being a well-known and frequently used option. Surface anesthesia does allow for atraumatic needle penetration.\[[@ref14]\] The density of the palatal soft tissues and their firm adherence to the underlying bone make palatal injection painful. It has been claimed that articaine is able to diffuse through soft and hard tissues more reliably than other local anesthetics and that maxillary buccal infiltration of articaine provides palatal soft-tissue anesthesia, obviating the need for a palatal injection which in many hands, is traumatic.\[[@ref14][@ref15]\]

Previous studies have been done on single buccal infiltration of articaine during maxillary premolar extraction and found to be effective.\[[@ref16]\] As the maxillary first molar has thick zygomatic buttress bone, so there is a need to evaluate the success of articaine during the first molar extraction.

The purpose of this study is to evaluate the efficacy of single buccal infiltration of 4% articaine in comparison with 2% lignocaine in maxillary first molar extraction.

Aim {#sec2-1}
---

This study aims to compare the efficacy of single buccal infiltration of 4% articaine with that of 2% lignocaine in maxillary first molar extraction.

Objectives {#sec2-2}
----------

To assess the presence or absence of pain in buccal gingiva after single buccal infiltration using the objective methodTo assess the presence or absence of pain in palatal gingivaTo record number and type of rescue injectionsTo record the subjective pain during the procedure using visual analog scale (VAS)To record the quality of anesthesia as evaluated by the surgeon using standard parametersTo measure the duration of the anesthesia.

M[ETHODOLOGY]{.smallcaps} {#sec1-2}
=========================

Source of data {#sec2-3}
--------------

A triple-blind randomized controlled study was carried on 100 patients of the age group of 18--60 years who required maxillary 1^st^ molar extraction, visiting the department of oral and maxillofacial surgery were included in the study after obtaining informed consent. They were included in the study randomly.

### Type of study {#sec3-1}

This was a triple-blind prospective comparative study.

### Duration of study {#sec3-2}

The duration of the study was December 2015--July 2017.

Criteria for selection of patients for the study {#sec2-4}
------------------------------------------------

### Inclusion criteria {#sec3-3}

Patients who require maxillary first molar extraction due to appropriate causes (apical periodontitis, dental caries, root stumps, and prior to prosthodontic rehabilitation). Patients are not having any acute periapical infection in relation to maxillary first molar. Patients are in the age group of 18--60 years.

### Exclusion criteria {#sec3-4}

Inadividuals with any previous history of complications associated with local anesthetic administration. The presence of acute infection or swelling. Those with teeth showing mobility. Patients having sickle cell anemia diseases. Pregnant women and lactating mother. Patients were unable to give informed consent.

Materials {#sec2-5}
---------

SEPTANEST^®^ (Articaine HCl. 4% with Epinephrine 1:100,000 Injection) manufactured by Septodont, France (Marketed by Septodont Healthcare India Pvt. Ltd., Maharashtra)LIGNOSPAN (Lignocaine HCl. 2% and Epinephrine 1:100,000) dental cartridges manufactured by Septodont, France (Marketed by Septodont Healthcare India Pvt. Ltd., Maharashtra)Septoject sterile 27-gauge disposable needles manufactured by Septodont, France (Marketed by Septodont Healthcare India Pvt. Ltd., Delhi)Rescue injections - Lignox 2% Lignocaine HCl. 2% and Epinephrine 1:80,000 manufactured by INDOCO Remedies Gujarat India.

Method of collection of data {#sec2-6}
----------------------------

Cartridges were blinded by covering the manufacturer sticker with paper and randomly allocating the numbers from 1 to 100 by a separate person other than the investigatorAfter obtaining the informed consent given in format, and taking intraoral periapical radiograph (to rule out any periapical pathology) each patient was randomly allocated to the studyBuccal infiltration along the long axis in the area between the two buccal roots of molar was givenAll injections were accomplished by one person, with slow injection technique (approximately 1 ml/min) and full cartridge (1.8 ml of solution) was deposited submucosallyThe objective symptoms in buccal and palatal gingiva were assessed after 5 min, and if the patient complains of pain, then appropriate rescue injections (palatal infiltration and posterior superior alveolar block) were given and mentioned in the case history pro formaExtraction was performed on each patient using either 4% articaine or 2% lignocaine but in cartridges labeled from 1 to 100 using appropriate blinding procedure. During extraction, the patient was continuously questioned about painVAS scores (scale given by Wong-Baker) were obtained immediately after the extraction procedure \[[Figure 1](#F11){ref-type="fig"}\]Recording of the VAS scores was done by the patientFollowing the surgery, the standard postoperative instructions were given to the patients along with the antibiotics and analgesics as and when requiredPatients were monitored till the anesthetic effect wears off.

![VAS score measurement scale](AMS-9-239-g011){#F11}

Clinical parameters {#sec2-7}
-------------------

Instrumentation (objective assessment with the help of sharp end of the periosteal elevator) was done on buccal gingiva as to assess the presence or absence of pain and the results were recordedInstrumentation (objective assessment with the help of sharp end of the periosteal elevator) was done on palatal gingiva to assess for the presence or absence of pain and the results were recordedThe type and number of rescue injections were recordedSubjective pain was evaluated using VAS scale The pain evaluation was done by the patient using VAS. The VAS was composed of an unmarked, continuous, horizontal, 100-mm line, anchored by the endpoints of "no pain" on the right and "worst pain" on the leftThe quality of anesthesia during the surgery as evaluated by the surgeonThis is based on three-point category rating scale:\[[@ref17]\]1 = no discomfort reported by the patient during surgery2 = any discomfort reported by the patient during surgery3 = any discomfort reported by the patient during surgery requiring additional anesthesia.Duration of postoperative anesthesia.

Measured by objective symptoms of pain checked every 5 min for 50 min from infiltration (including the time taken for extraction). Pain on instrumentation was regarded as a sign of wearing off of anesthesia.

All the extraction procedures were performed under 50 min, and if the patient experienced pain interfering with the procedure (moderate pain), an additional injection was given.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Twenty-six males and 24 females participated in Group A and 28 males and 22 females participated in Group B \[[Table 1](#T1){ref-type="table"} and [Graph 1](#F1){ref-type="fig"}\]. A mean age of 38.2 years in Group A and 38.4 in Group B was found \[[Table 2](#T2){ref-type="table"} and [Graph 2](#F2){ref-type="fig"}\]. All the extractions were simple tooth extractions and bone removal was not required in any of the cases.

###### 

Distribution of sex in the group

  Sex      Group A   Group B   %age
  -------- --------- --------- ------
  Male     26        28        54
  Female   24        22        46
  Total    50        50        100

###### 

Age group distributions in the group

  Age Group (yrs)   20-29   30-39   40-49   50-59   Total   Mean
  ----------------- ------- ------- ------- ------- ------- ------
  Group A           9       22      13      6       50      38.2
  Group B           8       15      18      9       50      38.4

![Distribution of sex in the group](AMS-9-239-g001){#F1}

![Age group distributions in the group](AMS-9-239-g002){#F2}

Pain on buccal instrumentation {#sec2-8}
------------------------------

The pain on buccal instrumentation was measured as present or absent. Group A and Group B showed no statistically significant difference between Group A buccal pain and Group B buccal pain \[[Table 3](#T3){ref-type="table"} and [Graph 3](#F3){ref-type="fig"}\], which indicates both Group A and Group B are equally effective in a reduction in pain.

###### 

Pain on buccal instrumentation

            *n*   Buccal pain   Chi square value   *P*   
  --------- ----- ------------- ------------------ ----- -----
  Group A   50    0             50                 Nil   Nil
  Group B   50    0             50                       

![Pain on buccal instrumentation](AMS-9-239-g003){#F3}

### Pain on palatal instrumentation {#sec3-5}

[Table 4](#T4){ref-type="table"} shows Mann--Whitney U-test in between Group A and Group B among the pain on palatal instrumentation, which shows highly statistical significant difference between them (*P* = 0.001) which indicates palatal pain was less experienced by Group A (Mean rank = 39) compared with Group B (Mean Rank = 62). [Graph 4](#F4){ref-type="fig"} represents the number of patients having palatal pain present or absent in both Group A and B.

###### 

Pain on palatal instrumentation

            *n*   Frequency of palatal pain   Mean rank   *P*     
  --------- ----- --------------------------- ----------- ------- -------
  Group A   50    6 (6%)                      44 (44%)    39.00   0.001
  Group B   50    29 (29%)                    21 (21%)    62.00   

![Pain on palatal instrumentation](AMS-9-239-g004){#F4}

### Number of rescue injections {#sec3-6}

The number of rescue injections used in Group A was 6 and that in Group B was 29 \[[Table 5](#T5){ref-type="table"} and [Graph 5](#F5){ref-type="fig"}\].

###### 

Number of rescue injections

                                Group A   Group B
  ----------------------------- --------- ---------
  Number of rescue injections   6         29

![Number of rescue injections](AMS-9-239-g005){#F5}

### Type of rescue injections {#sec3-7}

The type of rescue injections given in both the groups were single palatal infiltration of 0.5 ml of Lignocaine HCl. 2% with 1:80,000 Epinephrine.

### VAS score after extraction {#sec3-8}

VAS scores after extraction in Group A were: none for 0 patients (0%), mild for 44 patients (88%), moderate for 6 patients (12%), and severe for 0 patients (0%) \[[Graph 6](#F6){ref-type="fig"}\]. VAS scores after extraction in Group B were: none for 0 patients (0%), mild for 21 patients (42%), moderate for 29 patients (58%), and severe for 0 patients (0%) \[[Graph 7](#F7){ref-type="fig"}\]. Comparison of both the groups gives a statistically significant result \[Tables [6](#T6){ref-type="table"}, [7](#T7){ref-type="table"} and [Graph 8](#F8){ref-type="fig"}\].

![Visual Analog Scale score in group A](AMS-9-239-g006){#F6}

![Visual Analog Scale score in group B](AMS-9-239-g007){#F7}

###### 

Mann- Whitney test- Visual analog scale score

  Groups    *n*   Mean rank   Sum of ranks
  --------- ----- ----------- --------------
  Group 1   50    35.23       1761.50
  Group 2   50    65.77       3288.50
  Total     100               

###### 

*P* Visual Analog Scale score

                    VAS score
  ----------------- -----------
  Mann- Whitney U   486.500
  Wilcoxon W        1761.500
  *Z*               -5.516
  *P*               0.001

![Comparison of Visual Analog Scale score in group A and group B](AMS-9-239-g008){#F8}

### Quality of the anesthesia {#sec3-9}

There was no statistically significant difference between the quality of anesthesia provided by the local anesthetic agent in both groups \[Tables [8](#T8){ref-type="table"}, [9](#T9){ref-type="table"} and [Graph 9](#F9){ref-type="fig"}\].

###### 

Mann-Whitney test-quality of anesthesia

  Groups    *n*   Mean Rank   Sum of Ranks
  --------- ----- ----------- --------------
  Group 1   50    37.59       1879.50
  Group 2   50    63.41       3170.50
  Total     100               

###### 

*P* quality of anesthesia

                    Quality of anesthesia
  ----------------- -----------------------
  Mann- Whitney U   604.500
  Wilcoxon W        1879.500
  *Z*               -4.937
  *P*               0.001

![Quality of anesthesia](AMS-9-239-g009){#F9}

### Duration of postoperative anesthesia {#sec3-10}

The mean duration of postoperative anesthesia in Group A was (71.70 ± 18.01 min) in 44 patients which only received buccal infiltration. In Group B cases, 29 patients had received additional injections, so excluding those cases 21 cases the duration of anesthesia was noted. Of those 21 cases, in 1 case, the anesthetic effect was subsided before 50 min. Rest 20 cases showed the mean duration of about (56.25 ± 6.00 min) \[[Table 10](#T10){ref-type="table"} and [Graph 10](#F10){ref-type="fig"}\].

###### 

Duration of anesthesia

  Group     *n*   Mean    Std. Deviation
  --------- ----- ------- ----------------
  Group A   44    71.70   18.01
  Group B   20    56.25   6.00

![Duration of anesthesia](AMS-9-239-g010){#F10}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Articaine first appeared in German literature in the year 1969 and referred to as carticaine.\[[@ref4]\] Being an amide-type local anesthetic, it contains a carboxylic ester group, thus is inactivated in the liver as well as by hydrolyzation in the tissue and the blood. The main metabolic product is articainic acid (or more accurately: Articainic carboxylic acid), which is nontoxic and inactive as a local anesthetic. Articaine has a reputation of providing a good local anesthetic effect.\[[@ref18]\] Articaine is administered as a 4% local anesthetic solution. This different concentration of local anesthetic agents is because of the difference in their local anesthetic potency and lipid solubility. Agents with lower lipid solubility coefficients are marketed at higher concentrations than those with higher lipid solubility coefficients. Lipid solubility coefficient for articaine is 40.\[[@ref19]\] Equal analgesic efficacy along with lower systemic toxicity (i.e., a wide therapeutic range) allows the use of articaine in higher concentrations than other amide-type local anesthetics.\[[@ref20]\] The onset of anesthesia with 4% articaine with epinephrine 1:200,000 is 1.5--1.8 min for maxillary infiltration.\[[@ref21]\] Lemay *et al.*\[[@ref22]\] found an average time to onset of anesthesia (as determined by electrical stimulation of the pulp) for both concentrations (1:100,000 concentration and 1:200,000 concentration) with maxillary infiltration to be (105.0 s ± 49.2 scanning electron microscope \[SEM\] vs. 118.6 s ± 83.6 SEM, respectively). In comparing articaine with lidocaine solutions in maxillary infiltration, Costa *et al.*\[[@ref23]\] found statistically significant faster onset with 4% articaine (1:100,000 and 1:200,000 epinephrine) when compared with 2% lidocaine with 1:100,000 epinephrine. However, the onset times of 1.6, 1.4, and 2.8 min for the three solutions had onset differences of around a minute and would not be clinically significant.

In our study, the objective signs were measured 5 min after the injection as time is needed for the diffusion of solution to the palatal side which was in accordance with the study conducted by Srinivasan *et al.*,\[[@ref24]\] and Uckan *et al.*\[[@ref12]\] On the contrary, Kandasamy *et al.*\[[@ref25]\] took a latency time of 10 min to extract the maxillary tooth. A study conducted by Khan and Qazi\[[@ref26]\] concluded that all the successful cases for buccal infiltration of 2% lignocaine had achieved palatal anesthesia by 5 min, whereas the study conducted by Kumaresan *et al.*\[[@ref27]\] found out that 8.5--10 min latency period is required to achieve palatal anesthesia in the molar region when only a buccal infiltration of lidocaine local anesthetic solution is administered. In our study, all the individuals were anaesthetized on the buccal side using 4% articaine or 2% lignocaine, after 5 min on the palatal side using objective methods of the assessment of pain only 21 patients were anesthetized whereas rest experienced pain on palatal instrumentation in lignocaine group and 44 patients out of 50 were anesthetized in articaine group. A study conducted by Kandasamy *et al.*\[[@ref25]\] and by Sharma *et al.*\[[@ref28]\] found that 91.38% and 93.75% (*n* = 80) patients (using VAS scale) in articaine group experienced no pain on palatal instrumentation which were similar to our results whereas on the contrary all the cases for lignocaine group experienced pain which was contrary to our study. Khan and Qazi\[[@ref26]\] found that single buccal infiltration of 1.7 ml solution of 2% lignocaine with 1:100,000 epinephrine with 5 min of latency shows 28% successes (no pain on palatal instrumentation) and 40% success rate in the posterior maxilla. Sekhar *et al.*\[[@ref29]\] found no statistically significant difference in pain on palatal instrumentation with depositing of 2 ml of 2% lignocaine with 1:80,000 buccally or 1.7 ml buccally and 0.25 ml palatally with latency period of 8 min. Additional 6 (12%) rescue injections were used in Group A and 29 (58%) in Group B which were palatal infiltration of 2% lignocaine with 1:80,000 epinephrine. The results for articaine were similar to the study conducted by Luqman *et al.*\[[@ref30]\] which uses additional 16 (16%) rescue injections; however, the solution used was articaine for palatal infiltration. A study conducted by Somuri *et al.*\[[@ref15]\] demonstrated that articaine administered alone as single buccal infiltration provides favorable anesthesia as compared to buccal and palatal injection of lidocaine for extraction of maxillary premolars. Uckan *et al.*,\[[@ref12]\] Srinivasan *et al.*,\[[@ref24]\] and Kandasamy *et al.*\[[@ref25]\] also demonstrated that permanent maxillary teeth can be removed without palatal injection by giving buccal infiltration of articaine. On the contrary, a study conducted by Evans *et al.*\[[@ref31]\] showed that a maxillary infiltration of 4% articaine with 1:100,000 epinephrine statistically improved anesthetic success when compared with 2% lidocaine with 1:100,000 epinephrine in the lateral incisor but not in the first molar. Local anesthetic solutions with low pH have been thought to cause a burning sensation and thus more pain than anesthetics with more neutral pH.\[[@ref32][@ref33]\] Since articaine has a slightly higher pH (3.5--4), it produces less pain on injection also. When surveying the patients on quality of anesthesia, statistically significant differences were found between the two solutions in our study. Articaine provides better quality of anesthesia. The mean duration of postoperative analgesia with articaine was (71.70 ± 17.82 min) in 44 patients who only received buccal infiltration, results similar to those by Hassan *et al.*,\[[@ref16]\] Darawade *et al.*,\[[@ref34]\] Costa *et al.*\[[@ref23]\] whereas for lignocaine group, the mean duration was about (56.25 ± 5.92 min) for 20 cases who received buccal infiltration only. In one case, the anesthetic effect subsided before 50 min, and in that case, extraction procedure was performed by 20 min. The results were in accordance with study conducted by Darawade *et al.*\[[@ref34]\] The long period of analgesia for articaine finds explanation in a study by Oertel *et al.*\[[@ref20]\] who reported that the concentration of articaine in the alveolus of a tooth after extraction was about 100 times higher than in systemic circulation. Moreover, the long duration of postoperative analgesia evoked by articaine may be explained by its ability to readily diffuse through tissues due to the presence of a thiophene group in the molecule, which increases its liposolubility.\[[@ref35]\]

The safety of the use of articaine has been a matter of debate. A study conducted by Hillerup *et al.*\[[@ref36]\] showed the articaine 4% presented with the highest incidence of neurosensory disturbance with mandibular nerve being most commonly affected. High incidence of neurosensory disturbance was seen in solutions with higher concentrations of anesthetic agents. Kämmerer *et al.*\[[@ref37]\] showed local anesthetic effects of 2% articaine are comparable to 4% articaine. In Germany, a 2% formulation in association with 1:200,000 epinephrine has recently become available for dental use, which proved as effective as 4% concentration in teeth extractions with infiltration anesthesia.\[[@ref35]\] Hence, the use of a higher concentration of articaine is debatable. One thing should be kept in mind that overreporting of problems is natural when a new drug is introduced to the practice.\[[@ref38]\] Malamed *et al.*\[[@ref39]\] conducted a study and found that 4% Articaine with 1:1,00,000 epinephrine is a safe and effective local anesthetic for use in pediatric dentistry. A study done by van Oss *et al.*\[[@ref5]\] found adverse events such as headache, facial edema, infection, gingivitis, and paresthesia. El-Qutob *et al.*\[[@ref40]\] also reported a case of immediate skin reaction with articaine whereas Chisci *et al.*\[[@ref41]\] reported a case of trochlear nerve palsy using 4% articaine during posterior superior alveolar nerve block. In the present study, no signs or symptoms of paresthesia, nervousness, dizziness, tremors, blurred eyes, or any indication of adverse effects on the cardiovascular and central nervous systems in any subject with either articaine or lignocaine were found.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

This study concluded that:

The pain experienced during the single buccal injection of articaine is significantly less as compared to lignocaineEfficacy of single buccal injection of articaine is comparable to buccal and palatal injection of lignocaineMaxillary 1^st^ molars can be extracted by giving only buccal infiltration of articaine thereby obviating the need for the poorly tolerated palatal injection.

The choice of local anesthetic depends on several factors: length of the procedure, need for hemostasis, need for postoperative analgesia and whether any contraindications exist to the administration of the selected local anesthetic. Although lidocaine is considered as the gold standard local anesthetic for most dental procedures, articaine is a good substitute. However, further studies with larger sample size are warranted to substantiate our results.
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